vTv Therapeutics Inc. (VTVT)
Develops oral medicines to treat type 1 diabetes and other chronic diseases.
$31.08+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+113.2%
The outlook
VTVT trades at $31.08 with unanimous Strong Buy ratings from six analysts, whose average price target sits roughly 75% above the current price. The stock sits in the middle of its 52-week range but trades below both its 50- and 200-day moving averages, suggesting near-term weakness despite analyst optimism.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 6 analysts
Price trendBelow its 50- & 200-day averages
52-week range57% of the way from its 52-week low to high
Price targetAvg target +75% vs current price
Analyst price target
~12-month · 6 analysts$54.33average target+74.8% vs now
Now $31.08
Low $44.00High $67.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$122.4M
52-wk high
$44.00
52-wk low
$14.00
50-day avg
$33.79
200-day avg
$33.07
Trailing P/E
—